Earnings Per Share, Diluted of ZEVRA THERAPEUTICS, INC. from 31 Mar 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
ZEVRA THERAPEUTICS, INC. annual and quarterly Earnings Per Share, Diluted in USD/shares history and change rate from 31 Mar 2015 to 31 Dec 2025.
  • ZEVRA THERAPEUTICS, INC. Earnings Per Share, Diluted for the quarter ending 30 Sep 2025 was -0.01, a 99% increase year-over-year.
  • ZEVRA THERAPEUTICS, INC. annual Earnings Per Share, Diluted for 2025 was 1.35.
  • ZEVRA THERAPEUTICS, INC. annual Earnings Per Share, Diluted for 2024 was -2.28.
  • ZEVRA THERAPEUTICS, INC. annual Earnings Per Share, Diluted for 2021 was -2.11, a 34% increase from 2020.
Source SEC data
View on sec.gov
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)

ZEVRA THERAPEUTICS, INC. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 1.35 +3.63 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 -2.28 01 Jan 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
2021 -2.11 +1.1 +34% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2022 2021 FY
2020 -3.21 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY

ZEVRA THERAPEUTICS, INC. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 -0.01 +0.68 +99% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 1.21 +1.69 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q3 2024 -0.69 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 -0.48 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q4 2021 -2.11 0.84 +1.66 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2022 2021 FY
Q3 2021 -3.77 -0.06 +0.62 +91% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 -4.39 -0.4 -0.61 -290% 01 Apr 2021 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 -3.78 -2.49 -0.57 -30% 01 Jan 2021 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 -3.21 -0.82 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 -0.68 -0.74 -1233% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 0.21 +0.54 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
Q1 2020 -1.92 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q3 2019 0.06 +1 01 Jul 2019 30 Sep 2019 10-Q 30 Oct 2020 2020 Q3
Q2 2019 -0.33 +0.58 +64% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q2
Q3 2018 -0.94 -0.26 -38% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 -0.91 -0.47 -107% 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019 2019 Q2
Q4 2017 -2.95 -0.72 -0.04 -5.9% 01 Oct 2017 31 Dec 2017 10-K 30 Mar 2018 2017 FY
Q3 2017 -2.91 -0.68 +0.24 +26% 01 Jul 2017 30 Sep 2017 10-K 30 Mar 2018 2017 FY
Q2 2017 -3.15 -0.44 +0.14 +24% 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018 2018 Q2
Q1 2017 -3.29 -1.11 -0.91 -455% 01 Jan 2017 31 Mar 2017 10-K 30 Mar 2018 2017 FY
Q4 2016 -2.38 -0.68 -0.04 -6.2% 01 Oct 2016 31 Dec 2016 10-K 30 Mar 2018 2017 FY
Q3 2016 -2.34 -0.92 -0.24 -35% 01 Jul 2016 30 Sep 2016 10-K 30 Mar 2018 2017 FY
Q2 2016 -2.1 -0.58 +1.87 +76% 01 Apr 2016 30 Jun 2016 10-K 30 Mar 2018 2017 FY
Q1 2016 -3.97 -0.2 +2.3 +92% 01 Jan 2016 31 Mar 2016 10-K 30 Mar 2018 2017 FY
Q4 2015 -6.27 -0.64 01 Oct 2015 31 Dec 2015 10-K 10 Mar 2017 2016 FY
Q3 2015 -0.68 01 Jul 2015 30 Sep 2015 10-K 10 Mar 2017 2016 FY
Q2 2015 -2.45 01 Apr 2015 30 Jun 2015 10-K 10 Mar 2017 2016 FY
Q1 2015 -2.5 01 Jan 2015 31 Mar 2015 10-K 10 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.